The Bacillus Calmette-Guérin (BCG) is a live attenuated tuberculosis vaccine that has the
ability to induce non-specific cross-protection against pathogens that might be unrelated to …

A number of new tuberculosis (TB) vaccines have been or are entering clinical trials, which
include genetically modified mycobacteria, mycobacterial antigens delivered by viral …

Mycobacterium tuberculosis (M. tb), the causative agent of tuberculosis (TB), is the current
leading cause of death due to a single infectious organism. Although curable, the broad …

Bacillus Calmette Guérin (BCG) is the only currently available vaccine against tuberculosis
(TB), but it confers incomplete and variable protection against pulmonary TB in humans and …

Tuberculosis (TB) is a leading cause of death worldwide despite the availability of effective
chemotherapy for over 60 years. Although Mycobacterium bovis bacillus Calmette-Guérin …

Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is still a major threat to
mankind, urgently requiring improved vaccination and therapeutic strategies to reduce TB …

Abstract Bacillus Calmette-Guérin (BCG) has been used for vaccination against tuberculosis
for nearly a century. Here, we analyze immunity induced by a live tuberculosis vaccine …

Abstract Bacillus Calmette–Guérin (BCG), the only vaccine proven to be effective against
tuberculosis (TB), is the most commonly used vaccine globally. In addition to its effects on …

Traditional vaccine development against infectious diseases has been guided by the
overarching aim to generate efficacious vaccines normally indicated by an antibody and/or …

Bacille Calmette–Guérin (BCG), an attenuated vaccine derived from Mycobacterium bovis, is
the current vaccine of choice against tuberculosis (TB). Despite its protection against active …